Keywords: spectacular, data, actelion, tracleer, pht, say, msdw

"Spectacular data" from Actelion's Tracleer in PHT, say MSDW analysts

Article | 29 November 2000

Print This

Initiating coverage of Swiss biopharmaceuticals company Actelion,analysts at Morgan Stanley Dean Witter give it a strong buy rating, noting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in